Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-(2-methoxyethyl)-4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)benzenesulfonamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule containing a benzenesulfonamide group, a pyrimidine ring, and an imidazole moiety. It is listed as an experimental drug in chemical and pharmacological databases but does not have an assigned therapeutic indication or detailed mechanism of action in the public domain. The structure suggests it may act as a kinase inhibitor or modulator of enzymes/receptors involved in cell signaling, but no specific biological target or clinical use has been established. It is primarily referenced in research contexts and chemical libraries for screening purposes[1][3][6].
- Other names
- N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDEN-(2-methoxyethyl)-4-{[4-[2-methyl-1-(propan-2-yl)-1H-imidazol-5-yl]pyrimidin–2–yl}amino)benzene–1–sulfonamide4-{[4-(1-isopropyl–2–methyl–1H-imidazol–5–yl)–2-pyrimidinyl]amino}-N-(2-methoxyethyl)benzenesulfonamide
02
Targets
CDK2 (Cyclin-dependent kinase 2)
Beyond the preview
Go deeper on N-(2-methoxyethyl)-4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)benzenesulfonamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-(2-methoxyethyl)-4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)benzenesulfonamide.